What Is TB-500?
A Thymosin Beta-4-Derived Peptide Under Study in Tissue Repair and Wound-Healing Pathways
TB-500 is a synthetic peptide derived from a short region of thymosin beta-4, a naturally occurring peptide involved in cellular processes associated with tissue maintenance and repair. Specifically, TB-500 corresponds to the actin-binding region of thymosin beta-4 that has attracted research interest for its potential role in cell migration and blood vessel formation.
It has attracted scientific interest because the broader thymosin beta-4 pathway has been studied extensively in tissue repair, wound healing, angiogenesis, and cellular migration. However, research on full-length thymosin beta-4 cannot automatically be applied to TB-500, and direct evidence specifically involving TB-500 is much more limited.
TB-500 is not FDA-approved as a treatment for wound healing, tissue regeneration, muscle or joint recovery, injury recovery, or inflammation.
Have questions about peptide therapy? Call Advanced Mobile IV to speak with our team.
What Researchers Are Studying
-
Cell Migration and Tissue Repair
The region of thymosin beta-4 represented by TB-500 contains an actin-binding sequence associated with cellular movement. Researchers have studied this region because cell migration is an important component of normal wound healing and tissue repair.
-
Blood Vessel Formation
Thymosin beta-4 research has demonstrated effects on angiogenesis, the formation of new blood vessels, and its actin-binding region has been investigated for its role in this activity. These findings have contributed to interest in TB-500 and related peptides in regenerative research.
-
Wound-Healing Pathways
Full-length thymosin beta-4 has been studied extensively in laboratory and animal models of wound healing and tissue repair. Researchers continue to investigate which regions of the peptide contribute to these biological effects, although direct evidence establishing comparable wound-healing effects from TB-500 itself remains limited.
Quick Answer
TB-500 is a synthetic peptide corresponding to a short actin-binding region of thymosin beta-4. Researchers are interested in this region because thymosin beta-4 biology has been associated with cell migration, angiogenesis, and tissue repair. Direct clinical evidence for TB-500 itself, however, is extremely limited, and its therapeutic use remains investigational.
At a Glance
What it is
A synthetic peptide corresponding to the actin-binding region of the naturally occurring peptide thymosin beta-4.
Why it attracts attention
Researchers are interested in this peptide region because of its relationship to biological processes involving cell migration, blood vessel formation, and tissue repair.
What the evidence looks like
Full-length thymosin beta-4 has substantial preclinical research behind it, but direct research on TB-500 is much more limited, with a lack of established human clinical evidence.
Important context
TB-500 and full-length thymosin beta-4 are related but are not identical, and findings involving thymosin beta-4 should not automatically be attributed to TB-500.
What We Know - and What Remains Unclear
The biological relationship between TB-500 and thymosin beta-4 provides a scientific reason for continued research, particularly because the sequence represented by TB-500 is associated with actin binding and cellular migration.
However, much of what is commonly claimed about TB-500 is extrapolated from research involving full-length thymosin beta-4 rather than TB-500 itself. Claims that TB-500 reliably accelerates injury recovery, repairs muscle or connective tissue, reduces inflammation, improves mobility, or speeds wound healing have not been established by robust human clinical evidence.
Anyone considering peptide therapy should have an individualized conversation with a qualified provider who can discuss the current evidence, limitations, health history, medications, laboratory information, and recovery considerations.
Wellness, Delivered With Care
"Getting IV fluids when I was feeling ill was so beneficial to my healing. I'm grateful for AMIV and the service they provide. I would recommend everyone try this."
Jeff Weaver
Customer
"Very professional. The owners explained this treatment in detail. The procedure I received helped with fatigue and dehydration. I enjoyed the relaxed atmosphere of being in my own home."
Jennifer Belch
Customer
"I have had multiple experiences with Advance Mobile IV and all have been AMAZING! Painless pokes and incredible results, make me feel 100 times better. So thankful I found this company."
Cortlin Beck
Customer
Frequently Asked Questions
Is TB-500 the same as Thymosin Beta-4?
No. TB-500 is a short synthetic peptide derived from a specific region of thymosin beta-4. Although the two are closely related, they are not interchangeable, and research involving full-length thymosin beta-4 cannot automatically be applied to TB-500.
Why is TB-500 associated with tissue repair?
TB-500 corresponds to a region of thymosin beta-4 involved in actin binding and cellular migration. Because cell migration is important in tissue repair and wound healing, researchers have investigated the biological activity of this peptide sequence.
Has TB-500 been proven to accelerate injury recovery?
No. Direct human clinical evidence for TB-500 is extremely limited, and robust clinical trials have not established it as an effective treatment for accelerating recovery from muscle, tendon, joint, surgical, or other injuries.
Is TB-500 FDA-approved for regenerative therapy?
No. TB-500 is not FDA-approved as a treatment for tissue regeneration, wound healing, inflammation, injury recovery, muscle or joint repair, or improved mobility.
Learn More About Peptide Therapy
Peptide science is complicated, particularly when research involving a naturally occurring peptide is applied to one of its smaller fragments. Advanced Mobile IV can help you understand the current conversation around TB-500 and other peptide therapies, the questions to ask, and whether a discussion with a qualified provider makes sense for you.
Call Advanced Mobile IV to Learn MoreThis page is for educational purposes only and is not medical advice. Research and clinical understanding of peptide therapy continue to evolve.
AMIV Wellness Hub
Recent Blog Posts
Mobile IV
Jan 08, 2026
